Correlation Between Biomedix Incubator and Israel China

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biomedix Incubator and Israel China at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biomedix Incubator and Israel China into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biomedix Incubator and Israel China Biotechnology, you can compare the effects of market volatilities on Biomedix Incubator and Israel China and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biomedix Incubator with a short position of Israel China. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biomedix Incubator and Israel China.

Diversification Opportunities for Biomedix Incubator and Israel China

-0.71
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Biomedix and Israel is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Biomedix Incubator and Israel China Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Israel China Biotech and Biomedix Incubator is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biomedix Incubator are associated (or correlated) with Israel China. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Israel China Biotech has no effect on the direction of Biomedix Incubator i.e., Biomedix Incubator and Israel China go up and down completely randomly.

Pair Corralation between Biomedix Incubator and Israel China

Assuming the 90 days trading horizon Biomedix Incubator is expected to generate 3.93 times less return on investment than Israel China. But when comparing it to its historical volatility, Biomedix Incubator is 6.98 times less risky than Israel China. It trades about 0.1 of its potential returns per unit of risk. Israel China Biotechnology is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  10,800  in Israel China Biotechnology on August 26, 2024 and sell it today you would earn a total of  51,200  from holding Israel China Biotechnology or generate 474.07% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Biomedix Incubator  vs.  Israel China Biotechnology

 Performance 
       Timeline  
Biomedix Incubator 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Biomedix Incubator are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Biomedix Incubator sustained solid returns over the last few months and may actually be approaching a breakup point.
Israel China Biotech 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Israel China Biotechnology are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak fundamental drivers, Israel China may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Biomedix Incubator and Israel China Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biomedix Incubator and Israel China

The main advantage of trading using opposite Biomedix Incubator and Israel China positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biomedix Incubator position performs unexpectedly, Israel China can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Israel China will offset losses from the drop in Israel China's long position.
The idea behind Biomedix Incubator and Israel China Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets